Topical acne drugs: review of clinical properties, systemic exposure, and safety.
about
Topical azelaic acid, salicylic acid, nicotinamide, and sulphur for acneTreatment Modalities for AcneDevelopmental Neurotoxic Effects of Percutaneous Drug Delivery: Behavior and Neurochemical Studies in C57BL/6 MiceThe management of acne vulgaris in pregnancy.Treatment of acne vulgaris during pregnancy and lactation.Side effects of common acne treatments.Contact dermatitis to topical acne drugs: a review of the literature.A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.Potassium channel activator attenuates salicylate-induced cochlear hearing loss potentially ameliorating tinnitusPharmacotherapy of acne.Practical considerations in acne treatment and the clinical impact of topical combination therapy.LE135, a retinoid acid receptor antagonist, produces pain through direct activation of TRP channels.Topical absorption and systemic toxicity.Overview of the treatment of acne vulgaris with topical retinoids.Bacterial resistance and impetigo treatment trends: a review.Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of dicarboxylic acids, salts, and esters.Cosmeceuticals based on Rhealba(®) Oat plantlet extract for the treatment of acne vulgaris.Adverse effects of acne medications: recognition and management.Bioavailability of Clindamycin From a New Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3% Combination Gel.Synchronizing Pharmacotherapy in Acne with Review of Clinical Care.Allergic Contact Dermatitis to Benzoyl Peroxide Resembling Impetigo.[Acne therapy in pregnancy].Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies.Increased Skin Irritation by Hydroquinone and Rsetinoic Acid Used in Combination.Comparative study of the bactericidal effects of 5-aminolevulinic acid with blue and red light on Propionibacterium acnes.Allergic contact dermatitis caused by topical antiacne drugs.
P2860
Q24188298-CFD758F7-3129-4714-987D-44F010355D6DQ26741233-22EB13AB-5A7B-4518-A569-DA577D7A9077Q28553935-9CB890AA-D39E-429E-840D-BDF72133E044Q31135745-311F4336-A1A2-4B0A-BE44-4D4EE55E86A5Q34343682-D33ECD30-D107-47C0-BF52-BEBC6CDA43C7Q34481055-A07E191C-4E3B-4C4A-852F-62872D00E528Q34490756-339152AC-1A6A-46CC-ACDE-AB24FB14711CQ34569241-7E6445BA-1CDE-4F31-A686-06E49EB91670Q35296511-5D4E87E2-4FC9-4F3E-9250-8679EB00D8B9Q37123406-FC661022-EFC7-4EFF-9105-9DD794C9D0A3Q37169658-F482CD3F-8BF7-414C-8C4A-9FC975FE8AE5Q37637780-F7A22151-D2FE-4F4C-9BF9-60DF0E9F9675Q37855800-4312A379-916F-4835-A0CC-F46FDB8B2995Q37874895-90A374D7-5006-450A-A4F9-92F4B72861A5Q37980796-E05CB3C6-3152-4E88-91A5-6DD41DCF06BBQ38032543-6D6A7134-DC19-43BD-A2FA-D74AC7864239Q38271838-E5D7BC33-5D1B-4C40-8F58-FB6140B13212Q38432225-BE4E6379-4693-46D7-9D9C-1440BDBDD2F3Q39816530-C462D430-4137-4C37-A087-B3F85D266AADQ41129273-65461A2D-0824-45DD-B43B-8C0E748ADC9AQ41420326-0DCBF77B-80B4-4ED1-9C77-3B148C2BF55AQ43412631-FF19FD78-E88F-4827-9AB4-05DD8E4A4E24Q46862734-6B974A5C-1D69-4351-8DD1-7D7A67F17CA9Q47105548-C6E4AA5E-FB4E-45FD-A482-164DD262F8C9Q50282522-174B1EA2-2ADF-441A-95DC-34756ACCF812Q53503452-59215FED-4AC2-431A-9367-4F670EF23455
P2860
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
@ast
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
@en
type
label
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
@ast
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
@en
prefLabel
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
@ast
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
@en
P1476
Topical acne drugs: review of clinical properties, systemic exposure, and safety.
@en
P2093
Arash Akhavan
Susan Bershad
P304
P356
10.2165/00128071-200304070-00004
P577
2003-01-01T00:00:00Z
P6179
1051919424